21 CFR Subpart B
Labeling Requirements for Prescription Drugs and/or Insulin
June 25, 2020
§
201.55
Statement of dosage
§
201.50
Statement of identity
§
201.51
Declaration of net quantity of contents
§
201.56
Requirements on content and format of labeling for human prescription drug and biological products
§
201.57
Specific requirements on content and format of labeling for human prescription drug and biological products described in §201.56(b)(1)
§
201.58
Waiver of labeling requirements
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
